SONG Ziyi, ZHANG Shengxiao, ZHAO Rong, QIAO Jun, SONG Shan, CHENG Ting, WANG Caihong, LI Xiaofeng. Characteristics of Gut Microbiota and Their Association with Lymphocyte Subsets and Disease Activity in Ankylosing Spondylitis[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 821-830. DOI: 10.12290/xhyxzz.2022-0064
Citation: SONG Ziyi, ZHANG Shengxiao, ZHAO Rong, QIAO Jun, SONG Shan, CHENG Ting, WANG Caihong, LI Xiaofeng. Characteristics of Gut Microbiota and Their Association with Lymphocyte Subsets and Disease Activity in Ankylosing Spondylitis[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 821-830. DOI: 10.12290/xhyxzz.2022-0064

Characteristics of Gut Microbiota and Their Association with Lymphocyte Subsets and Disease Activity in Ankylosing Spondylitis

Funds: 

National Natural Science Foundation of China 82001740

More Information
  • Corresponding author:

    LI Xiaofeng, E-mail: lxf_9859@sxmu.edu.cn

  • Received Date: February 15, 2022
  • Accepted Date: August 01, 2022
  • Available Online: September 05, 2022
  • Issue Publish Date: September 29, 2022
  •   Objective  To investigate the characteristics of gut microbiome and their associations with lymphocyte subsets and disease activity in patients with ankylosing spondylitis (AS).
      Methods  This study was a retrospective analysis. The subjects of the study were AS patients who were hospitalized in the Second Hospital of Shanxi Medical University from December 2019 to June 2020, as well as gender- and age-matched healthy controls (HCs). The fecal samples were collected, and the V3-V4 variable regions of 16S rRNA gene of gut microbiome were sequenced for bioinformatics analysis. Peripheral venous blood was collected from AS patients to determine peripheral blood lymphocyte subsets and disease activity indicators. Spearman correlation test was used to analyze the correlations between the relative abundances of gut microbiota and peripheral blood lymphocyte subsets as well as disease activity in AS patients.
      Results  A total of 62 AS patients (11 with low disease activity, 26 with high disease activity, and 25 with extremely high disease activity) and 62 healthy people who met the inclusion and exclusion criteria were enrolled. As for α-diversity, ACE and Chao1 indices were lower in AS than in HCs(P < 0.05). Bray curtis distance-based β-diversity analysis revealed significant difference in the microbial community between AS and HCs (P < 0.01). As for the composition of the gut microbiome, Firmicutes, Bacteroidetes, and Proteobacteria were the dominant phyla in the gut microbiota of both groups, but there were differences in the abundance of various bacteria at the phylum and genus levels. In Stamp analysis, fecal microbial communities in AS differed significantly from those in HCs, which were characterized by higher abundances of phylum Proteobacteria and Patescibacteria(all P < 0.05) and a lower abundance of phylum Firmicutes and Fusobacteriota (all P < 0.05). At the genus level, the abundances of Escherichia-Shigella, Klebsiella and Enterococcus were increased while those of Prevotella and Faecalibacterium were decreased in AS patients compared to HCs(all P < 0.05). Spearman correlation analysis showed that the relative abundances of Faecalibacterium, Ruminococcus and Klebsiella in AS patients were significantly positively correlated with disease activity or its related indicators(all P < 0.05). There were positive correlations between Agathobacter and T cell (r=0.302, P=0.017), CD4+T cell (r=0.310, P=0.014), B cell (r=0.292, P=0.021), Th2 cell (r=0.429, P < 0.001), Th17 cell (r=0.288, P=0.023), Streptococcus and B cell (r=0.270, P=0.034), Prevotella and Th1 cell (r=0.279, P=0.028), Th17 cell (r=0.262, P=0.040), CAG-352 and Th1 cell (r=0.283, P=0.030). There were negative correlations between Escherichia-Shigella and Th2 cell(r=-0.261, P=0.040), other Enterobacteriaceae and CD4+T cell (r=-0.255, P=0.046).
      Conclusions  The diversity of gut microbiota is reduced in AS patients. The abundance of pathogenic bacteria in AS patients is increased, which is correlated with changes in peripheral blood lymphocyte subsets and disease activity. Dysbiosis may be involved in the occurrence and development of AS.
  • [1]
    Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis-insights into pathogenesis[J]. Nat Rev Rheumatol, 2016, 12: 81-91. DOI: 10.1038/nrrheum.2015.133
    [2]
    Simone D, Al Mossawi MH, Bowness P. Progress in our understanding of the pathogenesis of ankylosing spondylitis[J]. Rheumatology (Oxford), 2018, 57: vi4-vi9. DOI: 10.1093/rheumatology/key001
    [3]
    Zhou C, Zhao H, Xiao XY, et al. Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis[J]. J Autoimmun, 2020, 107: 102360. DOI: 10.1016/j.jaut.2019.102360
    [4]
    Rosenbaum JT, Davey MP. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome[J]. Arthritis Rheum, 2011, 63: 3195-3198. DOI: 10.1002/art.30558
    [5]
    Costello ME, Ciccia F, Willner D, et al. Brief report: Intestinal Dysbiosis in Ankylosing Spondylitis[J]. Arthritis Rheumatol, 2015, 67: 686-691. DOI: 10.1002/art.38967
    [6]
    Dominguez-Lopez ML, Burgos-Vargas R, Galicia-Serrano H, et al. IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients[J]. Scand J Rheumatol, 2002, 31: 260-265. DOI: 10.1080/030097402760375133
    [7]
    van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria[J]. Arthritis Rheum, 1984, 27: 361-368. DOI: 10.1002/art.1780270401
    [8]
    Aranda-Valera IC, Garrido-Castro JL, Ladehesa-Pineda L, et al. How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: The BASDAI-based ASDAS formula[J]. Rheumatology (Oxford), 2020, 59: 1545-1549. DOI: 10.1093/rheumatology/kez480
    [9]
    Lynch SV, Pedersen O. The human intestinal microbiome in health and disease[J]. N Engl J Med, 2016, 375: 2369-2379. DOI: 10.1056/NEJMra1600266
    [10]
    Zhang L, Han R, Zhang X, et al. Fecal microbiota in patients with ankylosing spondylitis: Correlation with dietary factors and disease activity[J]. Clin Chim Acta, 2019, 497: 189-196. DOI: 10.1016/j.cca.2019.07.038
    [11]
    Chen Z, Qi J, Wei Q, et al. Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis[J]. Ann Transl Med, 2019, 7: 571. DOI: 10.21037/atm.2019.09.41
    [12]
    Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J]. Ann Rheum Dis, 2017, 76: 1614-1622. DOI: 10.1136/annrheumdis-2016-211064
    [13]
    Liu G, Hao Y, Yang Q, et al. The Association of Fecal Microbiota in Ankylosing Spondylitis Cases with C-reactive Protein and Erythrocyte Sedimentation Rate[J]. Mediators Inflamm, 2020, 2020: 8884324.
    [14]
    Ciccia F, Guggino G, Rizzo A, et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis[J]. Ann Rheum Dis, 2017, 76: 1123-1132. DOI: 10.1136/annrheumdis-2016-210000
    [15]
    Asquith M, Sternes PR, Costello ME, et al. HLA Alleles Associated With Risk of Ankylosing Spondylitis and Rheumatoid Arthritis Influence the Gut Microbiome[J]. Arthritis Rheumatol, 2019, 71: 1642-1650. DOI: 10.1002/art.40917
    [16]
    Ebringer A, Ghuloom M. Ankylosing spondylitis, HLA-B27, and klebsiella: cross reactivity and antibody studies[J]. Ann Rheum Dis, 1986, 45: 703-704. DOI: 10.1136/ard.45.8.703
    [17]
    Pedersen SJ, Maksymowych WP. The Pathogenesis of Ankylosing Spondylitis: an Update[J]. Curr Rheumatol Rep, 2019, 21: 58. DOI: 10.1007/s11926-019-0856-3
    [18]
    Antoniou AN, Lenart I, Kriston-Vizi J, et al. Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication[J]. Ann Rheum Dis, 2019, 78: 74-82. DOI: 10.1136/annrheumdis-2018-213532
    [19]
    Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs coopera-tive study[J]. Arthritis Rheum, 1999, 42: 2325-2329. DOI: 10.1002/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C
    [20]
    Liu B, Yang L, Cui Z, et al. Anti-TNF-α therapy alters the gut microbiota in proteoglycan-induced ankylosing spondylitis in mice[J]. Microbiologyopen, 2019, 8: e927.
    [21]
    Ciccia F, Guggino G, Rizzo A, et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis[J]. Ann Rheum Dis, 2015, 74: 1739-1747. DOI: 10.1136/annrheumdis-2014-206323
    [22]
    Chua WJ, Truscott SM, Eickhoff CS, et al. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection[J]. Infect Immun, 2012, 80: 3256-3267. DOI: 10.1128/IAI.00279-12
    [23]
    Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine[J]. FEMS Microbiol Lett, 2009, 294: 1-8. DOI: 10.1111/j.1574-6968.2009.01514.x
    [24]
    Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T cell development by a commensal bacterium of the intestinal microbiota[J]. Proc Natl Acad Sci U S A, 2010, 107: 12204-12209. DOI: 10.1073/pnas.0909122107
    [25]
    Eastmond CJ, Willshaw HE, Burgess SE, et al. Frequency of faecal Klebsiella aerogenes in patients with ankylosing spondylitis and controls with respect to individual features of the disease[J]. Ann Rheum Dis, 1980, 39: 118-123. DOI: 10.1136/ard.39.2.118
    [26]
    Zhang L, Zhang YJ, Chen J, et al. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: A systematic review[J]. Microb Pathog, 2018, 117: 49-54. DOI: 10.1016/j.micpath.2018.02.020
    [27]
    van Bohemen CG, Grumet FC, Zanen HC. Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia[J]. Immunology, 1984, 52: 607-610.
    [28]
    Ebringer RW, Cawdell DR, Cowling P, et al. Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease[J]. Ann Rheum Dis, 1978, 37: 146-151. DOI: 10.1136/ard.37.2.146
    [29]
    Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progres-sion in early axial spondylarthritis[J]. Arthritis Rheum, 2012, 64: 1388-1398. DOI: 10.1002/art.33465
    [30]
    Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients[J]. Genome Med, 2017, 9: 103. DOI: 10.1186/s13073-017-0490-5
    [31]
    Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease[J]. Immunology, 2017, 151: 363-374. DOI: 10.1111/imm.12760
  • Related Articles

    [1]YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
    [2]The Committee of Chinese Laboratory Medical Education, Chinese Thoracic Society of the Chinese Medical Association. Expert Consensus on Nucleic Acid of Amplification Techniques Test for the Diagnosis of Pathogens in Adult Respiratory Tract Infections(2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 959-971. DOI: 10.12290/xhyxzz.2023-0338
    [3]LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
    [4]XIAO Nan, LI Zhanfeng, YAO Jianxin, PAN Zhiyao, YAO Zhifeng. Long Non-coding RNA and Cancer Stem Cells[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 373-379. DOI: 10.12290/xhyxzz.20190231
    [5]Beyond the NICU: Comprehensive Care of the High-risk Infant(2015)[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(6): 449-449.
    [7]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
    [8]Feng-xia YAO, Rui-fang SUI, Wei-min ZHANG, Yi DAI, Yu-pu GUO. Multiplex Ligation-dependent Probe Amplification Technology for Detection of Mitochondriopathy[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 104-108. DOI: 10.3969/j.issn.1674-9081.2013.02.004
    [9]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
    [10]Shuai TANG, Jie YI, Yu-guang HUANG. Cardiovascular Responses of Intubation with Shikani Seeing Optical Stylet and Macintosh Laryngoscope[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(3): 314-317. DOI: 10.3969/j.issn.1674-9081.2012.03.015
  • Cited by

    Periodical cited type(9)

    1. 齐素霞,王子月,袁莹,沈青青. 左西孟旦联合培哚普利叔丁胺治疗充血性心力衰竭的效果观察. 成都医学院学报. 2025(01): 66-69 .
    2. 孙晶,孟昌,白莹,郑山海. H2FPEF评分对非射血分数降低型心力衰竭患者预后的预测价值. 中国心血管病研究. 2025(01): 47-51 .
    3. 李杰,王雪梅. 放射性核素显像在射血分数保留的心力衰竭中的研究进展. 中国医学影像学杂志. 2025(02): 215-220 .
    4. 宋夏,朱婷,李湘燕,姚雯. 通脉养心丸联合沙库巴曲缬沙坦钠治疗慢性心力衰竭的临床研究. 现代药物与临床. 2025(03): 664-669 .
    5. 宋金玉,霍红秋,孙丽明,王丽晔,曹靓霞,戴运佳,冯宝静. 创新扩散理论结合多学科协作在重症肺炎合并心力衰竭患者中的应用. 实用临床医药杂志. 2025(06): 34-38+50 .
    6. 张富汉,王守富,于国俊,卢吉锋. 王守富治疗慢性心力衰竭经验. 河南中医. 2025(04): 538-543 .
    7. 刘知音,刘漫霞,卜婕,陈静,周玉. 改良护理方法对经胸右心声学造影患者血流动力学和舒适度的影响. 贵州医药. 2024(12): 1994-1996 .
    8. 游建丹,叶鹭萍,王晓斌. EECP结合运动训练的序贯式康复护理模式对心功能不全患者的干预研究. 心血管病防治知识. 2024(23): 131-133 .
    9. 刘珊珊. 心脏彩超在慢性心力衰竭中的诊断价值分析. 现代诊断与治疗. 2024(24): 3716-3717+3720 .

    Other cited types(0)

Catalog

    Article Metrics

    Article views (3592) PDF downloads (54) Cited by(9)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close